Yaron Tomer

Yaron Tomer, M.D., is a Professor in the Department of Medicine at Albert Einstein College of Medicine, specializing in thyroid immunology and autoimmune disorders. His research bridges clinical endocrinology with molecular genetics, focusing on the mechanisms underlying autoimmune thyroid diseases and their intersection with diabetes.

Dr. Tomer's research interests center on Autoimmune Thyroiditis, Graves' Disease, and Type 1 Diabetes, with particular emphasis on genetic susceptibility, epigenetic regulation, and environmental triggers. His work explores molecular pathways involving HLA-DR, thyroglobulin, and immune checkpoint molecules, integrating immunology with endocrine pathophysiology. Current projects investigate viral-induced autoimmunity and immune-related adverse events from cancer therapies.

Analysis of Dr. Tomer's recent publications reveals a strong trend toward translational research, with increasing focus on immune checkpoint inhibitor complications (2023-2025), retro-inverso peptide therapies (2023), and epigenetic mechanisms in thyroid autoimmunity (2023). His work consistently connects genetic findings to clinical applications, particularly in thyroid antigen presentation pathways.

Dr. Tomer has secured 13 major research grants totaling over two decades of continuous funding, including:

• National Institute of Diabetes and Digestive and Kidney Diseases project (2005-2025) on autoimmune thyroiditis and diabetes genes
• Active 2023-2024 project on immune checkpoint inhibitor-induced endocrine toxicity
• Multiple studies on thyroglobulin peptide presentation and viral triggers

His laboratory develops innovative mouse models of thyroid autoimmunity and investigates molecular pathways dysregulated in endocrine tissues. Current work focuses on translating genetic discoveries into targeted immune therapies for thyroid disorders, with growing emphasis on managing immunotherapy-related endocrine complications in cancer patients.